C12N 2770/16023
Virus like particles [vlp]
Official title: Virus like particles [VLP]
C12N2770/16023 (Virus like particles [vlp]) appears on 54 US grants and 84 published applications in this corpus.
Search patents in C12N- Granted patents
- 54
- Published applications
- 84
- Assignees
- 40
- Inventors
- 130
- Latest grant
- 31 Mar 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2005 | 0 | 1 |
| 2006 | 2 | 3 |
| 2007 | 0 | 0 |
| 2008 | 1 | 1 |
| 2009 | 1 | 3 |
| 2010 | 1 | 1 |
| 2011 | 2 | 3 |
| 2012 | 1 | 4 |
| 2013 | 3 | 6 |
| 2014 | 2 | 3 |
| 2015 | 1 | 2 |
| 2016 | 5 | 10 |
| 2017 | 0 | 0 |
| 2018 | 6 | 1 |
| 2019 | 5 | 5 |
| 2020 | 2 | 7 |
| 2021 | 2 | 4 |
| 2022 | 1 | 7 |
| 2023 | 8 | 6 |
| 2024 | 6 | 10 |
| 2025 | 3 | 3 |
| 2026 | 2 | 4 |
By publication year. 2026 runs to 8 Oct.
Recent patents
- Combined norovirus and rotavirus vaccine composition and methods of preparation31 Mar 2026US 12,589,144 B2Bharat Biotech International Limited
- Norovirus S particle based vaccines and methods of making and using same3 Feb 2026US 12,539,327 B2Children's Hospital Medical Center
- Methods of detection and removal of rhabdoviruses from cell lines25 Nov 2025US 12,479,891 B2Takeda Vaccines, Inc.
- Purification of virus like particles29 Apr 2025US 12,286,456 B2Takeda Vaccines, Inc.
- Human monoclonal antibodies that neutralize pandemic GII.4 noroviruses7 Jan 2025US 12,188,053 B2Baylor College of Medicine
- Recombinant expression vector for production of virus-like particle-based multivalent norovirus vaccine and manufacturing method therefor24 Sep 2026US 2026/0284173 A1Inthera Inc.
- Norovirus mrna vaccines10 Sep 2026US 2026/0263582 A1ModernaTX, Inc.
- Methods of detection and removal of rhabdoviruses from cell lines30 Jul 2026US 2026/0217770 A1Takeda Vaccines, Inc.
- Vp4-based trivalent pseudovirus nanoparticle vaccine for rotavirus and methods of using same9 Jul 2026US 2026/0191949 A1Children's Hospital Medical Center
- Endogenous plant expression enhancer26 Jun 2025US 2025/0207144 A1Aramis Biotechnologies Inc.
Most cited
By later US patents
- Norovirus vaccine formulations29US 7,955,603 B2Ligocyte Pharmaceuticals, Inc. · 2011
- Norovirus vaccine formulations26US 8,431,116 B2Takeda Vaccines (Montana), Inc. · 2013
- Virus-like particles comprising composite capsid amino acid sequences for enhanced cross reactivity25US 8,841,120 B2Takeda Vaccines, Inc. · 2014
- Small round structured virus (SRSV) detection kit21US 7,067,638 B1Denka Seiken Co., Ltd. · 2006
- Targeted heterologous antigen presentation on calicivirus virus-like particles20US 8,980,275 B2Takeda Vaccines, Inc. · 2015